Уважаемые коллеги! Это старая версия сайта Российского кардиологического общества. Страница не обновляется. Архив событий и новостей.
Для актуальной информации пройдите на scardio.ru
The FDA announced that it has approved cangrelor, an intravenous P2Y12 receptor antagonist, for the reduction of thrombotic events in adult patients with CAD undergoing PCI.
The aim of this study was to analyze and compare the effects of carvedilol and metoprolol on the development of contrast–induced nephropathy (CIN) in patients undergoing coronary angiography.
Whereas some studies suggest that statins exert a gastroprotective effect against gastrointestinal hemorrhage, others report that statin use is associated with increased risk of gastrointestinal hemorrhage.
“Go Red for Women” - social initiative aimed to focus attention of Russian women on prevention of cardiovascular diseases. Project is realized within the social and educational programme by Bayer – “Life Pulse”.
June 4, 2015 within the Republican scientific conference "Secondary prevention of cardiovascular diseases" held by Republican cardiological clinic RSC President and director of the Federal North-West Medical Research Centre (St.Petersburg) Professor Evgeny Shlyakhto presented a key lecture on heart failure.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.